abiraterone has been researched along with loratadine in 1 studies
Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (loratadine) | Trials (loratadine) | Recent Studies (post-2010) (loratadine) |
---|---|---|---|---|---|
942 | 97 | 854 | 1,317 | 462 | 339 |
Protein | Taxonomy | abiraterone (IC50) | loratadine (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 0.016 | |
Histamine H1 receptor | Homo sapiens (human) | 0.23 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.245 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1717 | |
Bile acid receptor | Homo sapiens (human) | 3.07 | |
Sodium-dependent neutral amino acid transporter B(0)AT2 | Homo sapiens (human) | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for abiraterone and loratadine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |